Almotriptan Malate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Almotriptan Malate
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Almotriptan Malate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 6 USDMF, 1 CEP/COS, 5 EU WC, 4 NDC API, 8 Listed Suppliers, $ API Reference Price

14 API Suppliers
6 USDMF
1 CEP/COS
5 EU WC
4 NDC API
8 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 8 FDA Orange Book, 11 Europe, 6 Canada

25 FDF Dossiers
8 FDA Orange Book
11 Europe
6 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 2 DKSH, 3 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 ACG Worldwide, 3 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 43 Fillers, Diluents & Binders, 31 Disintegrants & Superdisintegrants, 26 Controlled & Modified Release, 22 Direct Compression, 19 Granulation, 18 Thickeners and Stabilizers, 15 Chewable & Orodispersible Aids, 15 Solubilizers, 13 Taste Masking, 12 Co-Processed Excipients, 11 Film Formers & Plasticizers, 10 Topical, 9 Parenteral, 9 Lubricants & Glidants, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 3 Rheology Modifiers, 2 Emulsifying Agents

45 Coating Systems & Additives
43 Fillers, Diluents & Binders
31 Disintegrants & Superdisintegrants
26 Controlled & Modified Release
22 Direct Compression
19 Granulation
18 Thickeners and Stabilizers
15 Chewable & Orodispersible Aids
15 Solubilizers
13 Taste Masking
12 Co-Processed Excipients
11 Film Formers & Plasticizers
10 Topical
9 Parenteral
9 Lubricants & Glidants
5 Empty Capsules
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents
3 Rheology Modifiers
2 Emulsifying Agents

DIGITAL CONTENT

2 NEWS #PharmaBuzz

2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices

1 US Medicaid Prescriptions
4 Finished Drug Prices

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 1 Others

2 USP
1 Others

$ API Ref.Price (USD/KG) : 9,581 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2McNeil Consumer Healthcare

filter Patent Reset all filters

2 All

01 22120028

filter Product Reset all filters

2 All

01 2Almotriptan Malate

filter Dosage Reset all filters

2 All

01 2Tablet

filter Exp Date Reset all filters

2 All

01 22013-07-19

Product Main Page

01

McNeil Consumer Healthcare

Almotriptan Malate

The Generic Rx Session

Not Confirmed

McNeil Consumer Healthcare

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-07-19

Date Granted : 1999-03-23

Almotriptan Malate

Brand Name : AXERT

Patent Number : 2120028

Filing Date : 1993-07-19

Strength per Unit : 12.5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-07-19

Date Granted : 1999-03-23

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

McNeil Consumer Healthcare

Almotriptan Malate

The Generic Rx Session

Not Confirmed

McNeil Consumer Healthcare

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-07-19

Date Granted : 1999-03-23

Almotriptan Malate

Brand Name : AXERT

Patent Number : 2120028

Filing Date : 1993-07-19

Strength per Unit : 6.25mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-07-19

Date Granted : 1999-03-23

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!